Prevalence of Hyperuricemia in Patients with Ischemic Stroke
DOI:
https://doi.org/10.53350/pjmhs22166702Abstract
Introduction: An attack of stroke is one of the most prevalent but also the deadliest and most disabling conditions in the field of neurology. Stroke development is influenced by many risk factors, including high blood pressure, smoking, hyperlipidemia, and diabetes. Recent research suggests that other risk factors, such as elevated levels of blood uric acid, might influence the onset or progression of the condition.
Objective: To determine the prevalence of hyperuricemia in stroke patients.
Methods: The Department of Medicine, Khyber Teaching Hospital, Peshawar, did this cross-sectional research. Patients of both sexes were included in this trial from October 10th, 2019, through March 31st, 2020. who had ischemic stroke-related symptoms and imaging findings? Each patient who was proven to have had an ischemic stroke was examined for hyperuricemia, which means a blood uric acid level of more than 7 mg/dL in men and more than 6 mg/dL in women. All patients received the same level of care in the lab. After that, the prevalence of hyperuricemia in ischemic stroke patients were determined.Results: The average age of 60.833± 3.70 years was used in this investigation, along with mean serum uric acid concentration of 6.340± 2.06 mg/dl was examined for hyperuricemia, which means a blood uric acid level of more than 7 mg/dL in men and more than 6 mg/dL in women and mean period between onset of symptoms and admission of 5.993± 2.94. The vast majority of the patients were male gender (70 percent). Sixty patients were found to have hyperuricemia (40 percent).
Conclusion: According to our research, hyperuricemia was found in a more significant percentage of acute stroke patients than in the general population.
Keywords: Hyperuricemia, Stroke, Frequency
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.